The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes
Antiadhesion molecules are effective and safe in patients with ulcerative colitis (UC). Etrolizumab, a monoclonal antibody targeting both α 4 β 7 and α E β 7 , represents a promising therapy for patients with UC, since this novel mechanism of action may be effective in blocking leukocyte recruitment...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2016-07-01
|
| Colecção: | Therapeutic Advances in Gastroenterology |
| Acesso em linha: | https://doi.org/10.1177/1756283X16647935 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|